|
2021
|
Long-term effectiveness and safety of quadruplecombination therapy with empagliflozin versusdapagliflozin in patients with type 2 diabetes: 3-yearprospective observational study. DIABETES RESEARCH AND CLINICALPRACTICE 2021;182():1-10 |
2021
|
Effect of Dipeptidyl Peptidase‐4 Inhibitors on BoneHealth in Patients with Type 2 Diabetes Mellitus. JOURNAL OF CLINICAL MEDICINE 2021;10(20):4775- |
2021
|
Association between rs1761667 CD36 polymorphismand risk of stroke in Korean patients with type 2diabetes. CHINESE MEDICAL JOURNAL 2021;134(19):2385-2387 |
2021
|
RANTES 59029A/G Polymorphisms Associated withDiabetic Compilations in Korean Patients with Type 2Diabetes for over 15 Years. GENES 2021;12(9):- |
2021
|
Polymorphism in the HaeIII single nucleotidepolymorphism of the SLC2A1 gene and cardiovasculardisease in the early type 2 diabetes mellitus. DIABETES & VASCULAR DISEASERESEARCH 2021;18(5):1-4 |
2021
|
Identification of candidate gene variants of monogenicdiabetes using targeted panel sequencing in early onsetdiabetes patients. BMJ OPEN DIABETES RESEARCH & CARE 2021;9():1-8 |
2021
|
The Associations Between Vitamin D Receptor BsmI andApaI Polymorphisms and Obesity in Korean Patients withType 2 Diabetes Mellitus. DIABETES METABOLIC SYNDROME ANDOBESITY-TARGETS AND THERAPY 2021;14():557-564 |
2021
|
Psychometric Analysis Regarding the Barriers toProviding Effective Insulin Treatment in Type 2 DiabeticPatients. DIABETES THERAPY 2021;12(1):159-170 |
2020
|
Environmental surface testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during prolonged isolation of an asymptomatic carrier. EnM {2020} |
2020
|
Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database. DIabetes, obesity and metabolism {2020} |
2020
|
Metabolomics profiles associated with diabeticretinopathy in type 2 diabetes patients. PLOS ONE 2020;():1-12 |
2020
|
Relationship between Clinical Features of DiabeticRetinopathy and Systemic Factors in Patients with NewlyDiagnosed Type II Diabetes Mellitus. JOURNAL OF KOREAN MEDICAL SCIENCE 2020;35(23):- |
2020
|
Comparison of the Efficacy and Safety of Insulin DetemirAdministered Once Daily According to Two TitrationAlgorithms (3-0-3 and 2-4-6-8) in Patients with Type 2Diabetes Mellitus. ENDOCRINOLOGY AND METABOLISM 2020;35(1):142-148 |
2020
|
Efficacy and safety of gemigliptin as add-on therapy toinsulin, with or without metformin, in patients with type2 diabetes mellitus (ZEUS II study). DIABETES OBESITY & METABOLISM 2020;22(1):123-127 |
2020
|
Genetic variation in TCF7L2 rs7903146 correlating withperipheral arterial disease in long-standing type 2diabetes. DIABETES & VASCULAR DISEASERESEARCH 2020;17(1):- |
2019
|
Efficacy and safety of gemigliptin as add-on therapy to insulin with or without metformin in patients with type 2 diabetes mellitus (ZEUS II study) . Diabetes, Obesity & metabolism {2019} |
2019
|
Teneligliptin versus sitagliptin in Korean patients with type2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial. Diabetes, Obesity & metabolism {2019} |
2019
|
Metabolomics profiles associated with HbA1c levels inpatients with type 2 diabetes. PLOS ONE 2019;14(11):- |
2019
|
Associations between the HaeIII Single NucleotidePolymorphism in the SLC2A1 Gene and DiabeticNephropathy in Korean Patients with Type 2 DiabetesMellitus. JOURNAL OF KOREAN MEDICAL SCIENCE 2019;34(24):- |
2019
|
Empagliflozin versus dapagliflozin in patients with type 2diabetes inadequately controlled with metformin,glimepiride and dipeptidyl peptide 4 inhibitors: A52-week prospective observational study. DIABETES RESEARCH AND CLINICALPRACTICE 2019;151():65-73 |
2019
|
Teneligliptin versus sitagliptin in Korean patients withtype 2 diabetes inadequately controlled with metforminand glimepiride: A randomized, double-blind,non-inferiority trial. DIABETES OBESITY & METABOLISM 2019;21(3):631-639 |
2019
|
Effectiveness and safety of empagliflozin-basedquadruple therapy compared with insulin glargine-basedtherapy in patients with inadequately controlled type 2diabetes: An observational study in clinical practice. DIABETES OBESITY & METABOLISM 2019;21(1):173-177 |
2018
|
Dapagliflozin improves blood glucose in diabetes ontriple oral hypoglycemic agents having inadequateglucose control. DIABETES RESEARCH AND CLINICALPRACTICE 2018;142():188-194 |
2018
|
Association of Adiponectin 45T/G Polymorphism withDiabetic Cardiovascular Complications in Korean Type 2Diabetes. JOURNAL OF KOREAN MEDICAL SCIENCE 2018;33(17):124-133 |
2017
|
Efficacy and safety of gemigliptin, a dipeptidylpeptidase-4 inhibitors, in patients with type 2 diabetesmellitus inadequately controlled with combinationtreatment of metformin and sulfonylurea: a 24-week,multicentre, randomized, double-blind,placebo-controlled study (TROICA study). DIABETES OBESITY & METABOLISM 2017;19(5):635-643 |
